| Absorption | Oral bioavailability is 50-60%. |
| Volume of distribution | Not Available |
| Protein binding | Not Available |
| Metabolism | Following topical administration, synthesis into protoporphyrin IX takes place in situ in the skin. |
| Route of elimination | Not Available |
| Half life | Mean half-life is 0.70 ± 0.18 h after the oral dose and 0.83 ± 0.05 h after the intravenous dose. |
| Clearance | Not Available |
| Toxicity | Solution overdose have not been reported. |
| Affected organisms |
|
| Pathways | Not Available |
Aminolevulinic acid
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment